References
- Lind T, Cederberg C, Ekenved G, Haglund U, Olbe L. Effect of omeprazole - a gastric proton pump inhibitor - on pentagastrin stimulated acid secretion in man. Gut 1983; 24: 270–276
- Lind T, Cederberg C, Ekenved G, Olbe L. Inhibition of basal and betazole- and sham-feeding induced acid secretion by omeprazole in man. Scand J Gastroenterol 1986; 21: 1004–1010
- Londong W, Londong V, Cederberg C, Steffen H. Dose-response study of omeprazole on meal-stimulated gastric acid secretion and gastrin release. Gastroenterology 1983; 85: 1373–1378
- Müller P, Seitz H K, Simon B, Dammann H G. Sauresekretionsverhalten und Plasmaspiegel unter einer mehrtägigen Omeprazol-Gabe. Arzneimittel-forschung 1983; 33: 1685–1686
- Müller P, Seitz H K, Simon B, et al. Vierwöchige Omeprazol-Gabe: Einfluss auf Säureverhalten und basale Hormonspiegel. Z Gastroenterol 1984; 22: 236–240
- Lind T, Cederberg C, Axelson M, Olbe L. Long-term acid inhibitory effect of different daily doses of omeprazole 24 hours after dosing. Scand J Gastroenterol 1986; 21(suppl 118)137–138
- Lind T, Axelson M, Olbe L. Dose-response relationship of gastric acid inhibition in elderly patients after repeated administration of omeprazole. Dig Dis Sci 1986; 31(suppl)352S, (abstract)
- Sharma B K, Walt R P, Pounder R E, Gomes M, de F A, Wood E C, Logan L H. Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity. Gut 1984; 25: 957–964
- Prichard P J, Yeomans N D, Mihaly G W, et al. Omeprazole: A study of its inhibition of gastric pH and oral pharmacokinetics after morning or evening dosage. Gastroenterology 1985; 88: 64–69
- Naesdal J, Bankel N, Bodemar G, Gotthard R, Lundquist G, Walan A. The effect of 20 mg omeprazole daily on serum gastrin, 24-h intragastric acidity, and bile acid concentration in duodenal ulcer patients. Scand J Gastroenterol 1987; 22: 5–12
- Pritchard P J, Yeomans N D, Jones D B, Louis W J, Smallwood R A. Effect of morning or evening dosage with 10 mg omeprazole on 24 hour gastric pH in duodenal ulcer patients in remission. Gut 1984; 25(Al)181–1182, (abstract)
- Lanzon-Miller S, Pounder R E, Ball S, Hamilton M R, Chronos N AF, Raymond F. Twenty four hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole. Gut 1986; 27: A1255, abstract
- Brunner G, Creutzfeldt W, Harke U, Lamberts R. Therapy with omeprazole in patients with peptic ulcerations resistant to extended high-dose ranitidine treatment. Digestion 1988; 39: 80–90
- Lind T, Cederberg C, Forssell H, Olausson M, Olbe L. Relationship between reduction of gastric acid secretion and plasma gastrin concentration during omeprazole treatment. Scand J Gastroenterol, (in press)
- Festen H PM, Tuynman H ARE, Defize J, et al. Effect of single and repeated doses of oral omeprazole on gastric acid and pepsin secretion and fasting serum gastrin and serum pepsinogen I levels. Dig Dis Sci 1986; 31: 561–566
- Festen H PM, Thijs J C, Lamers C BHW, et al. Effect of oral omeprazole on serum gastrin and serum pepsinogen I levels. Gastroenterology 1984; 87: 1030–1034
- Sharma B, Axelson M, Pounder R P, et al. Acid secretory capacity and plasma gastrin concentration after administration of omeprazole to normal subjects. Aliment Pharmacol Ther 1987; 1: 67–76
- Lanzon-Miller S, Pounder R E, Hamilton M R, et al. Twenty-four-hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole. Aliment Pharmacol Ther 1987; 1: 239–251
- Lind T, Cederberg C, Olausson M, Olbe L. 24-hour intragastric acidity and plasma gastrin after omeprazole (OME) treatment or proximal gastric vagotomy (PGV) in duodenal ulcer (DU) patients. Gastroenterology 1988; 94: A265, (abstract)